top of page

Title: Australia stocks higher at close of trade; S&P/ASX 200 up 0.92%

Writer: analysiswatchanalysiswatch

Jun 15, 2021 03:45AM ET

By: AnalysisWatch

Australia shares had been better after the near on Tuesday, as profits the Healthcare, IT and Consumer Staples sectors led stocks better.

At the near in Sydney, the S&P/ASX 200 received 0.92% to hit a brand new all-time high.

The quality performers of the consultation at the S&P/ASX 200 had been Resmed Inc. DRC (ASX: RMD), which rose 6.84% or 1.940 factors to change at 30.310 on the near. Meanwhile, A2 Milk Company Ltd (ASX: A2M) brought 5.42% or 0.31 factors to stop at 6.03 and Iluka Resources Ltd (ASX: ILU) turned into up 5.00% or 0.390 factors to 8.190 in past due change.

The worst performers of the consultation had been Austal Ltd (ASX: ASB), which fell 9.01% or 0.21 factors to change at 2.12 on the near. Pointsbet Holdings Ltd (ASX: PBH) declined 6.49% or 0.89 factors to stop at 12.83 and Nickel Mines Ltd (ASX: NIC) turned into down 4.15% or 0.1/2 factors to 1.040.

Falling shares outnumbered advancing ones at the Sydney Stock Exchange with the aid of using 828 to 601 and 373 ended unchanged.

Shares in Resmed Inc. DRC (ASX: RMD) rose to all-time highs; growing 6.84% or 1.940 to 30.310. Shares in Austal Ltd (ASX: ASB) fell to 52-week lows; down 9.01% or 0.21 to 2.12.

The S&P/ASX 200 VIX, which measures the implied volatility of S&P/ASX 200 options, turned into up 7.56% to 12.186.



 
 
 

Commentaires


2b94f773-a237-4da7-a599-6b42314ed9e6.png

Risk Disclosure: AnalysisWatch will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors. Before deciding to trade foreign exchange or any other financial instrument you should carefully consider your investment objectives, level of experience, and risk appetite.
AnalysisWatch would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore AnalysisWatch doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

bottom of page